Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
暂无分享,去创建一个
[1] D. Talwar,et al. Plasma dimethylarginines during the acute inflammatory response , 2011, European journal of clinical investigation.
[2] Xinli Hu,et al. Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine , 2009, Circulation.
[3] F. Palm,et al. Cellular ADMA: regulation and action. , 2009, Pharmacological research.
[4] Yong Xia,et al. Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production* , 2009, The Journal of Biological Chemistry.
[5] D. Tsikas,et al. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications. , 2009, Nitric oxide : biology and chemistry.
[6] Zhaoguang Liang,et al. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. , 2008, Biochemical and biophysical research communications.
[7] M. Siroen,et al. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. , 2008, JPEN. Journal of parenteral and enteral nutrition.
[8] G. Van den Berghe,et al. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. , 2008, Endocrinology.
[9] Dan Wang,et al. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] Maristela L Onozato,et al. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.
[11] Maristela L Onozato,et al. Isoform-Specific Regulation by NG,NG-Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NO , 2007, Circulation research.
[12] D. Wilcken,et al. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. , 2007, Molecular genetics and metabolism.
[13] KoichiroHomma,et al. Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2 , 2007 .
[14] K. Homma,et al. Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2 , 2007, Circulation research.
[15] T. Teerlink,et al. HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] Roger Williams,et al. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] P. Vallance,et al. Disruption of methylarginine metabolism impairs vascular homeostasis , 2007, Nature Medicine.
[18] J. Zweier,et al. Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function* , 2007, Journal of Biological Chemistry.
[19] Roger Williams,et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis , 2007, Hepatology.
[20] F. Grimminger,et al. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[21] H. Prins,et al. The clinical significance of asymmetric dimethylarginine. , 2006, Annual review of nutrition.
[22] T. Teerlink,et al. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. , 2006, Analytical biochemistry.
[23] H. Katus,et al. Expression of nitric oxide related enzymes in coronary heart disease , 2006, Basic Research in Cardiology.
[24] R. Nijveldt,et al. No Compensatory Upregulation of Placental Dimethylarginine Dimethylaminohydrolase Activity in Preeclampsia , 2006, Gynecologic and Obstetric Investigation.
[25] S. Moncada,et al. The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.
[26] Xin Xu,et al. Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts. , 2005, American journal of physiology. Heart and circulatory physiology.
[27] T. Teerlink. ADMA metabolism and clearance , 2005, Vascular medicine.
[28] R. Nijveldt,et al. The human liver clears both asymmetric and symmetric dimethylarginine , 2005, Hepatology.
[29] G. Van den Berghe,et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality?* , 2005, Critical care medicine.
[30] E. Kuipers,et al. The transplanted liver graft is capable of clearing asymmetric dimethylarginine , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] M. Cuesta,et al. Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy. , 2004, JPEN. Journal of parenteral and enteral nutrition.
[32] M. Serra,et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. , 2004, Journal of hepatology.
[33] P. Tsao,et al. Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence , 2003, Circulation.
[34] H. Prins,et al. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] R. Johns,et al. Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary Hypertension , 2003, Circulation.
[36] P. Vallance,et al. Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[37] T. Teerlink,et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality , 2003, Clinical nutrition.
[38] R. Nijveldt,et al. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). , 2003, Clinical nutrition.
[39] N. Chan,et al. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? , 2002, Diabetologia.
[40] C. Stehouwer,et al. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[41] P. Tsao,et al. Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase , 2002, Circulation.
[42] R. Nijveldt,et al. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.
[43] W. Schlack,et al. Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] P. Tsao,et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. , 2002, JAMA.
[45] T. Hardy,et al. Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. , 2002, Free radical biology & medicine.
[46] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[47] D. Fliser,et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[48] J P Cooke,et al. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. , 2001, The American journal of cardiology.
[49] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[50] R. D'Hooge,et al. N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency , 2000 .
[51] R. D'Hooge,et al. NG,NG-Dimethylarginine and NG,N'G-dimethylarginine in renal insufficiency , 2000, Pflügers Archiv.
[52] E. Block,et al. A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”* , 1997, The Journal of Biological Chemistry.
[53] M. Clark,et al. Role of blood flow in the regulation of muscle glucose uptake. , 1997, Annual review of nutrition.
[54] P. V. van Leeuwen,et al. Plasma amino acids determined by liquid chromatography within 17 minutes. , 1994, Clinical chemistry.
[55] S. Moncada,et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure , 1992, The Lancet.
[56] M. Lou. Human muscular dystrophy: elevation of urinary dimethylarginines. , 1979, Science.
[57] J. Mcdermott,et al. Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. , 1976, The Biochemical journal.